Casey Mulligan, a principal economist from Trump’s Council of Economic Advisers between 2018 and 2019, clarified to The Western Journal how the previous U.S. administration managed to bring vaccines against the COVID-19 disease much earlier than anyone expected.

Mulligan underlined the policy efforts taken before the COVID-19 outbreak as critical to the success of the U.S. vaccine development program.

The crucial factor was the support the administration gave to innovation, as opposed to unnecessary bureaucracy and futile attention to details.

Mulligan pointed to the 2019 report by the Council of Economic Advisers, which identified vaccine development as the most important approach to combat any potential pandemic.

The economists behind the report instructed the administration to endorse new vaccine production and distribution methods, as opposed to the older ones which, even though being a less risky investment, showed significant drawbacks.


The report ended up being a building block of Trump’s Executive Order 13387, introduced on September 19th, 2019.

The order provided additional funds for companies working on alternative methods that promised much faster responses to public health hazards.

Even though the order specifically aimed at potential influenza virus spreading, it proved vital for the U.S. reaction to the COVID-19 outbreak.

The order made the regulatory approval of new medicines, including vaccines, much less troubled by bureaucratic scrutiny.

Mulligan emphatically pointed out that it is much worse to waste consumer’s time than to waste their money.

Former Trump advisor stressed that even though safety is very important, overthinking it should not come at the expense of speed.


Many experts believe that it would be hardly possible to start the human trial of Moderna’s COVID-19 vaccine on March 16th, 2020, just five days after WHO’s pandemic declaration, without Executive Order 13387.

The order was crucial in Trump’s initiation of Operation Warp Speed, the U.S. $10 billion worth program aimed at ending the pandemic.

The program’s support for innovative methods resulted in well-known events.

By the end of 2020, the newly introduced RNA method enabled the production of highly effective COVID-19 jabs from Pfizer and Moderna.

Curbing the pandemic

Today, newly developed vaccines show promise in ending the pandemic that killed more than 550,000 Americans.

The highest death toll in the U.S. occurred in early January when more than 3,500 American citizens were dying each day from the consequences of the virus.


Back then, the principal infectious disease scientist Anthony Fauci estimated that additional 300,000 people would die from the disease during the three upcoming months.

Fortunately, Fauci’s prognosis now seems to have been too pessimistic.

Even though many states, such as Texas and Mississippi, are lifting the majority of restrictions, the number of newly identified COVID-19 cases and deaths are steadily falling.

Many experts find the rapid vaccination campaign that covered nearly 30 percent of Americans by the end of March responsible for the decrease.

As Mulligan noted, such a success would have been hardly imaginable without Executive Order 13387 enacted several years ago.